BRIEF-Tolmar Pharmaceuticals receives FDA approval for eligard

Edit Reuters 06 May 2016
* Tolmar pharmaceuticals announces that fda approval has been received for eligard (leuprolide acetate for injectable suspension) storage at room temperature for up to 8 weeks Source text for Eikon. (Bengaluru Newsroom. +1 646 223 8780) ....

REACH Annex XVII Restriction on Phenylmercury Compounds (SGS SA)

Edit Public Technologies 06 May 2016
(Source. SGS SA). May 6, 2016. SAFEGUARDS . Consumer Products NO. 093/16. Commission Regulation (EU) No. 848/2012 amending Annex XVII to Regulation (EC) No. 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) as regards the restriction of phenylmercury compounds will become effective on 10th October 2017 ... table 1 ... Phenylmercury acetate 62-38-4 200-532-5 ... t....

Native American photographers respond to Edward Curtis' images 100 years later

Edit The Guardian 06 May 2016
19th-century photographer snapped photographs and defined America’s Indigenous peoples – now an exhibition invited contemporary artists to respond ... “I want them to make them live forever,” the photographer said ... (How many words in Crow do you know? Apache? Cherokee? Choctaw?) ... Wil Wilson’s photographs seem scratched onto the acetate – large VR goggles filming some of the frame with a gas mask clamped over his mouth in another ... Twitter ... ....

FTC Approves Modified Final Order Addressing Competitive Concerns about Hikma Pharmaceuticals PLC’s Acquisition of Roxane (Federal Trade Commission)

Edit Public Technologies 05 May 2016
(Source. Federal Trade Commission) ... and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation would likely be anticompetitive ... The order also requires Hikma to relinquish to its drug development partner, India-based Unimark Remedies Ltd., the rights to market flecainide acetate tablets in the United States and to divest its equity interest in Unimark ... (FTC File No ... (noodl....

ACETO Board of Directors Declares Quarterly Cash Dividend

Edit Stockhouse 05 May 2016
PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ.ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common ......

ACETO Board of Directors Declares Quarterly Cash Dividend (Aceto Corporation)

Edit Public Technologies 05 May 2016
(Source. Aceto Corporation). PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ.ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share ... ABOUT ACETO ... FORWARD LOOKING STATEMENTS ... (noodl....

STATEHOUSE UPDATE: More Than a Dozen OSMA-Tracked Bills Advance in the Legislature (Ohio State Medical Association)

Edit Public Technologies 05 May 2016
(Source. Ohio State Medical Association). May 5, 2016 ... Some of the bills affected were. ... HB 421 authorizes a licensed pharmacist to administer by injection an opioid antagonist used for treatment of drug addiction and administered in a long-acting or extended-release form, an antipsychotic drug administered in a long-acting or extended-release form, or the synthetic hormones hydroxyprogesterone caproate or medroxyprogesterone acetate....

ACETO Reports Fiscal 2016 Third Quarter Results (Aceto Corporation)

Edit Public Technologies 05 May 2016
(Source. Aceto Corporation). PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq.ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016 ... Management Commentary ... Guccione added ... Guccione concluded ... Conference Call....

United States Butyl Acetate Market Business Report 2016 - Research and Markets

Edit Business Wire 04 May 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Butyl Acetate Market in United States ... The report presents analysis of butyl acetate market in United States. Report Scope. Brief country profile includes general information and main economic indicators and specifies business environment in United States Butyl Acetate market is analyzed by different parameters including domestic production and consumption....

Cooper Hewitt's triennial design exhibit looks at 'Beauty'

Edit San Francisco Chronicle 04 May 2016
Nearby, in "ethereal," milliner Maiko Takeda's surreal headgear resembles giant fuzzy caterpillars, with bristles of thinly shredded acetate tinted with color gradients to evoke a sort of delicate synthetic fur that undulates with the slightest breeze ... ....

Yip’s Chemical Launches New Facebook and WeChat Official Accounts on its 45th Anniversary (Yip's Chemical Holdings Limited)

Edit Public Technologies 03 May 2016
00408) ('Yip's Chemical' or the 'Group'), the world's largest manufacturer of acetate solvents and one of China's largest manufacturers of petrochemical products, has announced the launch of its new official account on the leading global social network Facebook and China's social network WeChat to mark the Group's 45th anniversary....

Ace the style game with these spring must-haves

Edit New York Post 03 May 2016
Whether you’re festival bound or just fashion focused now that the sun is finally out, here’s how to upgrade your warm-weather wardrobe ... Gucci sunglasses, $1,190 at Solstice Sunglasses, 500 Fifth Ave.; “VivyAcetate Round Framed Sunglasses with Detachable Jewel Clip, $595 at Jimmy Choo, 111 Greene St.; “TOM N.2” sunglasses, $990 at tomford.com; Sunglasses, $1,105 at us.lindafarrow.comPhoto ... Photo ... ....

Momenta Pharmaceuticals Reports First Quarter 2016 Financial Results (Momenta Pharmaceuticals Inc)

Edit Public Technologies 03 May 2016
For the first quarter of 2016, the Company reported total revenues of $19.9 million, including $14.8 million in product revenues from Sandoz's sale of Glatopa® (glatiramer acetate injection) ... The ANDA submitted by Sandoz for a three-times-a-week generic COPAXONE® 40 mg (glatiramer acetate injection) is under FDA review....
×